Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Georges Gemayel
Age : 60
Public asset : 686,240 USD
Linked companies : Supernus Pharmaceuticals, Inc. - Gemini Therapeutics, Inc. - Orphazyme A/S
Summary 
Georges Gemayel is an American businessperson who has been at the helm of 11 different companies. Currently, Dr. Gemayel occupies the position of Chairman of OxThera AB, Chairman at Enterome SA, Chairman for Orphazyme A, Chairman of Dynacure SA and Chairman for Gemini Therapeutics, Inc. Georges Gemayel is also on the board of Supernus Pharmaceuticals, Inc., International Institute of New England, Gemayel Family Foundation and St Andrews School In Ngong, Inc. and Partner at Gemayel Investment LLC.

Dr. Gemayel previously occupied the position of Chairman, President & Chief Executive Officer of Altus Pharmaceuticals, Inc., Executive Chairman for Syndexa Pharmaceuticals Corp., Executive Chairman for Syndex Corp., Executive Chairman for Vascular Magnetics, Inc., Vice President-National Specialty Care at Roche Corp., Executive Chairman at FoldRx Pharmaceuticals, Inc., Chairman for EpiTherapeutics ApS, Executive Vice President-Therapeutics at Genzyme Corp., Vice President-National Specialty Care at Hoffmann-La Roche, Inc., General Manager for Hoffmann-La Roche Portugal and General Manager at Roche Farmaceutica Quimica Ltda.

Georges Gemayel received a doctorate from St. Joseph University and a doctorate and a graduate degree from Université de Paris XI Paris Sud.


Current positions of Georges Gemayel 
NameTitle Since
Supernus Pharmaceuticals, Inc.
(Pharmaceuticals)
Independent Director 2015
Gemini Therapeutics, Inc.
(Biotechnology & Medical Research)
Chairman 2021
Orphazyme A/S
(Biotechnology & Medical Research)
Chairman 2014
OxThera AB Chairman 2014
Dynacure SA Chairman 2018
Enterome SA Chairman 2015
International Institute of New England Director -
Gemayel Family Foundation Trustee -
St Andrews School In Ngong, Inc. Director -
Gemayel Investment LLC Partner 2012


Holdings of Georges Gemayel 
NameEquities%Valuation
Orphazyme A/S (ORPHA)
(Biotechnology & Medical Research)
100,8090.29%542,781 USD
Supernus Pharmaceuticals, Inc. (SUPN)
(Pharmaceuticals)
5,2110.0098%143,459 USD
Gemini Therapeutics, Inc. (GMTX)
(Biotechnology & Medical Research)
00.0000%0 USD


Georges Gemayel: Personal Network 
Most Read News 
09/04BERNARD ARNAULT : There is no conflict with Arnault
RE
09/07GEORGE SOROS : Soros says BlackRock's China investments likely to lose money - WSJ
RE
09/14BRAD SMITH : Microsoft to buy back up to $60 billion in shares; names Brad Smith vice chair
RE
09/09FRANCESCO GAETANO CALTAGIRONE : Italy's Caltagirone ups Generali stake to just over 6%
RE
09/14CATHIE WOOD : ARK Invest's Wood expects market rotation back to growth stocks
RE
09/09ELON MUSK : Tesla's Musk asks staff to 'go super hardcore' to ensure decent Q3 delivery number
RE
09/13MARTIN SORRELL : Sorrell's S4 Capital raises annual profit outlook for a third time
RE
09/08ELON MUSK : Amazon.com goes for jugular in FCC spat with SpaceX's Musk
RE
09/08BILL GATES : Bill Gates' investment firm to take control of Four Seasons in $2.21 billion deal
RE
09/17STELIOS HAJI-IOANNOU : EasyJet shareholder Stelios Haji-Ioannou shuns rights issue -source
RE
More news


© 2021 People and Ownership :   
Georges Gemayel : Connections